Table 1.
Demographics and comorbidities of patients who recovered vs not recovered from cardiac injury 2.5 months after hospital discharge from COVID-19. Group comparisons (recovery vs non-recovery) of categorical variables were performed using the Chi-squared test. Group comparison of continuous variables in medians and interquartile ranges (IQR) were performed using the Wilcoxon test. A p-value < 0.05 was considered statistically significant.
| Recovery(n=302) | Non-recovery(n=371) | p-value | |
|---|---|---|---|
| Demographics | |||
| Age, median (IQR) | 71 (59, 80) | 71 (61, 80) | 0.813 |
| Female sex, n (%) | 176 (58%) | 195 (53%) | 0.160 |
| Race, n (%) | 0.161 | ||
| White | 26 (9%) | 52 (14%) | |
| Black/African American | 132 (44%) | 135 (36%) | |
| Asian | 8 (3%) | 7 (2%) | |
| Other Pacific Islander | 0 | 1 (0.3%) | |
| Patient declined | 4 | 5 (1%) | |
| Other | 132 (44%) | 171 (46%) | |
| Ethnicity, n (%) | 0.732 | ||
| Hispanic | 127 (42%) | 162 (44%) | |
| Non-Hispanic | 175 (58%) | 209 (56%) | |
| Comorbidities, n (%) | |||
| Type-1 Diabetes | 17 (6%) | 11 (3%) | 0.127 |
| Type-2 Diabetes | 112 (37%) | 144 (39%) | 0.704 |
| Hypertension | 137 (45%) | 174 (47%) | 0.749 |
| Asthma | 26 (9%) | 30 (8%) | 0.917 |
| COPD | 13 (4%) | 30 (8%) | 0.066 |
| Coronary artery disease | 62 (21%) | 80 (22%) | 0.817 |
| Chronic kidney disease | 67 (22%) | 68 (18%) | 0.252 |
| Liver disease | 9 (3%) | 16 (4%) | 0.481 |
| Stroke | 30 (10%) | 43 (12%) | 0.574 |
| Heart failure | 91 (30%) | 114 (31%) | 0.934 |
| Length of hospital stay, median (IQR) | 8 (4, 16) | 8 (5, 13) | 0.289 |
Abbreviations: IQR, interquartile range. COPD, chronic obstructive pulmonary disease.